Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 19, 2026

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
12:27

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Published on: June 8, 2022

Targeting sphingosine-1-phosphate for cancer therapy.

R A Sabbadini1

  • 1Department of Biology, San Diego State University, 5500 Campanile Dr, San Diego, CA 92182-4614, USA. rsabba@sunstroke.sdsu.edu

British Journal of Cancer
|October 7, 2006
PubMed
Summary

Sphingosine-1-phosphate (S1P) promotes tumor growth and blood vessel formation. Targeting S1P and other lipid molecules offers a new therapeutic strategy for cancer and other diseases.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Essential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2α expression and activity in cancer.

Oncogenesis·2016
Same author

Myocardial cells in culture to study effects of cytokines.

Methods in molecular medicine·2011
Same author

Expression and characterization of Edg-1 receptors in rat cardiomyocytes: calcium deregulation in response to sphingosine 1-phosphate.

European journal of biochemistry·2000
Same author

The role of sphingolipids in the control of skeletal muscle function: a review.

Italian journal of neurological sciences·2000
Same author

LPS-induced TNF-alpha release from and apoptosis in rat cardiomyocytes: obligatory role for CD14 in mediating the LPS response.

Journal of molecular and cellular cardiology·1999
Same author

MKK6 activates myocardial cell NF-kappaB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner.

The Journal of biological chemistry·1998

Area of Science:

  • Oncology
  • Lipidomics
  • Molecular Biology

Background:

  • Sphingosine-1-phosphate (S1P) is a bioactive lipid mediator.
  • Tumor microenvironments are complex and influenced by secreted factors.
  • Cancer progression involves angiogenesis and tumor growth.

Purpose of the Study:

  • To review new findings on S1P's role in tumorigenesis and angiogenesis.
  • To explore S1P as a potential drug target in oncology.
  • To introduce lipidomic-based therapeutics for cancer treatment.

Main Methods:

  • Literature review of recent studies on S1P.
  • Analysis of S1P's function in the tumor microenvironment.
  • Discussion of drug design strategies targeting lipid signaling.

Main Results:

  • S1P is implicated as a key factor in promoting tumor growth.
  • S1P acts as a potent angiogenic agent in the tumor microenvironment.
  • Bioactive lipids like S1P represent novel targets for drug development.

Conclusions:

  • S1P plays a significant role in cancer progression.
  • Targeting S1P offers a promising therapeutic avenue in oncology.
  • Lipidomic-based therapies hold potential for treating various human diseases.

Related Experiment Videos

Last Updated: Jul 19, 2026

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
12:27

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Published on: June 8, 2022